Ginsenoside Rg1 delays the senescence of adipose-derived stem cells: network pharmacology and experimental validation

Key Points

• Delaying senescence occurs in adipose-derived stem cells as a result of ginsenoside Rg1 treatment, promoting cell longevity and functionality.
• Statistical analysis revealed a significant decrease in senescence markers under ginsenoside Rg1 influence, enhancing stem cell viability.
• Experimental validation confirms findings from network pharmacology, supporting ginsenoside Rg1's role in cell rejuvenation.
• These findings indicate potential therapeutic applications of ginsenoside Rg1, although further research is needed for clinical relevance.